ѻý
Edit Profile
Manage Subscriptions
CME Tracker
Log Out
Login
Sign Up
ѻý
Back
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology
Genetics
Geriatrics
HIV / AIDS
Hospital-Based Medicine
Infectious Disease
Nephrology
Neurology
Nursing
OB / GYN
Oncology / Hematology
Ophthalmology
Orthopedics
Pain Management
Pathology
Pediatrics
Pharmacy
Primary Care
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Transplantation
Urology
Perspectives
Health Policy
Meetings
Special Reports
Break Room
Conditions
Back
Condition Centers
DocAudio
Making the Rounds
Medical Journeys
Society Partners
Back
AAD Reading Room
ACR Reading Room
AGA Reading Room
ASCO Reading Room
Endocrine Society Reading Room
IDSA Reading Room
OMA Reading Room
Making the Rounds
>
AMD
New Treatment Options in Geographic Atrophy
Usha Chakravarthy, MD, PhD, shares her thoughts on two new treatment options in the management geographic atrophy, with our host Rahul Khurana, MD.
October 17, 2024 • 3 mins 4 secs
Up Next
New Treatment Options in Geographic Atrophy
▶ 3 mins
Complement Inhibition and Patient Selection
▶ 5 mins
Interpreting the Faricimab and Aflibercept Data
▶ 3 mins
Balancing Treatment and Stability in Diabetic Macular Edema
▶ 3 mins
Faricimab vs. Aflibercept in DME: Comparing Drying and Biomarker Outcomes
▶ 4 mins
Incorporating Aflibercept and Fariscimab into Practice
▶ 3 mins
Incorporating Eylea HD into Practice
▶ 2 mins